Compound Detail
CHEMBL296468
BMS-387032 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL296468 |
| Name | BMS-387032 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | OUSFTKFNBAZUKL-UHFFFAOYSA-N |
108
Targets
257
Activities
3
Assay Types
30
PK Parameters
20
Publications
4
Known Names
5
Indications
3
Mechanisms
Molecular Properties
380.5
MW (Da)
3.66
ALogP
7
HBA
2
HBD
80.0
PSA (Ų)
0.77
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cyclin-dependent kinase 2 inhibitor | INHIBITOR | Cyclin-dependent kinase 2 | ✓ | ✓ |
| Cyclin-dependent kinase 7 inhibitor | INHIBITOR | Cyclin-dependent kinase 7 | ✓ | ✓ |
| Cyclin-dependent kinase 9 inhibitor | INHIBITOR | Cyclin-dependent kinase 9 | ✓ | ✓ |
Indications
Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma, Mantle-Cell Multiple Myeloma Neoplasms Neoplasms
Activity Summary
Kd 150 meas. best 8.77
IC50 91 meas. best 9.0
Ki 16 meas. best 8.4
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| CDK9/cyclin T1 CHEMBL2111389 | IC50 | 9.0 | 8.313 | 1.0 | 10 |
| Cyclin-dependent kinase-like 5 CHEMBL1163112 | Kd | 8.77 | 8.77 | 1.7 | 1 |
| Cyclin-dependent kinase 17 CHEMBL5790 | Kd | 8.7 | 8.16 | 2.0 | 3 |
| Cyclin-dependent kinase 9 CHEMBL3116 | IC50 | 8.4 | 7.3343 | 4.0 | 7 |
| Cyclin-dependent kinase 9 CHEMBL3116 | Ki | 8.4 | 8.2 | 4.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 8.22 | 7.024 | 6.0 | 5 |
| Cyclin-dependent kinase 16 CHEMBL4597 | Kd | 8.15 | 7.75 | 7.1 | 3 |
| CDK2/Cyclin A1 CHEMBL3038470 | IC50 | 7.68 | 7.68 | 21.0 | 1 |
| Cyclin-dependent kinase 13 CHEMBL1795192 | Kd | 7.64 | 7.045 | 23.0 | 2 |
| Glycogen synthase kinase-3 alpha CHEMBL2850 | Kd | 7.55 | 7.27 | 28.0 | 3 |
| Cyclin-dependent kinase 7 CHEMBL3055 | Kd | 7.51 | 7.0067 | 31.0 | 3 |
| Cyclin-dependent kinase 9 CHEMBL3116 | Kd | 7.47 | 7.2367 | 34.0 | 3 |
| Glycogen synthase kinase-3 beta CHEMBL262 | Kd | 7.43 | 7.1267 | 37.0 | 3 |
| Cyclin-dependent kinase 2/cyclin E1 CHEMBL1907605 | IC50 | 7.42 | 7.345 | 38.0 | 4 |
| Cyclin-dependent kinase 2 CHEMBL301 | IC50 | 7.42 | 7.1164 | 38.0 | 11 |
| Cyclin-dependent kinase 2 CHEMBL301 | Ki | 7.42 | 7.42 | 38.0 | 1 |
| CDK2/Cyclin A2 CHEMBL3038469 | IC50 | 7.42 | 7.3733 | 38.0 | 3 |
| Cyclin-dependent kinase-like 2 CHEMBL5728 | Kd | 7.39 | 7.39 | 41.0 | 1 |
| Cyclin-dependent kinase 18 CHEMBL5316 | Kd | 7.36 | 7.36 | 44.0 | 2 |
| Cyclin-dependent kinase 2/cyclin E CHEMBL2094126 | IC50 | 7.32 | 6.32 | 48.0 | 3 |
| Cyclin-dependent kinase 11A CHEMBL5416 | Kd | 7.32 | 7.32 | 48.0 | 2 |
| Cyclin-dependent kinase 5 CHEMBL4036 | Ki | 7.3 | 7.3 | 50.1 | 1 |
| Cyclin-dependent kinase 1/cyclin B1 CHEMBL1907602 | IC50 | 7.28 | 6.4571 | 52.0 | 7 |
| Jurkat CHEMBL397 | IC50 | 7.28 | 7.28 | 53.0 | 1 |
| Cyclin-dependent kinase 3 CHEMBL4442 | Kd | 7.25 | 7.25 | 56.0 | 2 |
| Cyclin-dependent kinase 7/ cyclin H CHEMBL2111288 | IC50 | 7.21 | 7.21 | 62.0 | 4 |
| CDK7/Cyclin H/MNAT1 CHEMBL3038473 | IC50 | 7.21 | 7.0825 | 62.0 | 4 |
| Cyclin-dependent kinase 7 CHEMBL3055 | IC50 | 7.21 | 7.018 | 62.0 | 5 |
| Cyclin-dependent kinase 4 CHEMBL331 | Kd | 7.18 | 6.58 | 66.0 | 3 |
| Cyclin-dependent kinase 2 CHEMBL301 | Kd | 7.16 | 7.0033 | 69.0 | 3 |
| Cyclin-dependent kinase 4 CHEMBL331 | IC50 | 7.16 | 6.595 | 69.0 | 2 |
| RPMI-8226 CHEMBL614882 | IC50 | 7.1 | 6.9633 | 79.0 | 3 |
| A2780 CHEMBL614004 | IC50 | 7.02 | 7.02 | 95.0 | 2 |
| Cyclin-dependent kinase 11B CHEMBL5808 | Kd | 7.01 | 7.01 | 98.0 | 2 |
| Mitogen-activated protein kinase 15 CHEMBL5198 | Kd | 6.92 | 6.92 | 120.0 | 2 |
| Trypanosoma brucei CHEMBL612849 | IC50 | 6.92 | 6.92 | 120.0 | 1 |
| Glycogen synthase kinase-3 alpha CHEMBL2850 | Ki | 6.9 | 6.9 | 125.9 | 1 |
| Cyclin-dependent kinase 7 CHEMBL3055 | Ki | 6.9 | 6.9 | 125.9 | 1 |
| Cyclin-dependent kinase 6 CHEMBL2508 | Kd | 6.85 | 6.85 | 142.0 | 1 |
| Serine/threonine-protein kinase ICK CHEMBL1163126 | Kd | 6.82 | 6.82 | 150.0 | 1 |
| Maternal embryonic leucine zipper kinase CHEMBL4578 | Ki | 6.8 | 6.8 | 158.5 | 1 |
| Cyclin-dependent kinase 12 CHEMBL3559692 | Kd | 6.78 | 6.78 | 167.0 | 1 |
| MOLT-4 CHEMBL614177 | IC50 | 6.76 | 6.76 | 173.0 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B CHEMBL5543 | Kd | 6.7 | 6.7 | 200.0 | 2 |
| Cyclin-dependent kinase 8 CHEMBL5719 | Ki | 6.7 | 6.7 | 199.5 | 1 |
| Glycogen synthase kinase-3 alpha CHEMBL2850 | IC50 | 6.64 | 6.64 | 230.0 | 1 |
| Glycogen synthase kinase-3 beta CHEMBL262 | Ki | 6.6 | 6.6 | 251.2 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B CHEMBL5543 | Ki | 6.6 | 6.6 | 251.2 | 1 |
| Serine/threonine-protein kinase 36 CHEMBL4312 | Kd | 6.58 | 6.58 | 260.0 | 2 |
| Cyclin-dependent kinase 5/CDK5 activator 1 CHEMBL1907600 | IC50 | 6.47 | 6.47 | 340.0 | 3 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1522.16 | ng.hr.mL-1 | Mus musculus |
| AUC | 1826.59 | ng.hr.mL-1 | Mus musculus |
| AUC | 2397.4 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 799.13 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 1510.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 434.0 | ng.hr.mL-1 | Mus musculus |
| CL | 81.0 | mL.min-1.kg-1 | Mus musculus |
| CL | 64.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 9.4 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 55.0 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 1300.0 | nM | Mus musculus |
| Cmax | 1400.0 | nM | Mus musculus |
| Cmax | 520.0 | nM | Rattus norvegicus |
| Cmax | 330.0 | nM | Canis lupus familiaris |
| Cmax | 5860.09 | nM | Mus musculus |
| Cmax | 722.66 | nM | Mus musculus |
| F | 100.0 | % | Mus musculus |
| F | 31.0 | % | Rattus norvegicus |
| F | 28.0 | % | Canis lupus familiaris |
| F | 31.0 | % | Rattus norvegicus |
| F | 14.0 | % | Mus musculus |
| F | 31.0 | % | Rattus norvegicus |
| MRT | 3.5 | hr | Mus musculus |
| MRT | 2.8 | hr | Mus musculus |
| MRT | 3.7 | hr | Rattus norvegicus |
| MRT | 6.3 | hr | Canis lupus familiaris |
| T1/2 | 2.5 | hr | Mus musculus |
| T1/2 | 4.8 | hr | Mus musculus |
| T1/2 | 5.3 | hr | Rattus norvegicus |
| T1/2 | 7.0 | hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5303300 | HEK-293T | 304 |
| - | 10.6019/CHEMBL5303300 | U2OS | 304 |
| - | 10.6019/CHEMBL5303300 | Fibroblast | 304 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 262 |
| - | 10.6019/CHEMBL4689842 | U2OS | 261 |
| - | 10.6019/CHEMBL4689842 | HEK-293T | 260 |
| 15027863 | 10.1021/jm0305568 | Mus musculus | 18 |
| 19169685 | 10.1007/s00280-008-0921-5 | RPMI-8226 | 18 |
| 22037378 | 10.1038/nbt.1990 | Tyrosine-protein kinase ABL1 | 15 |
| 19169685 | 10.1007/s00280-008-0921-5 | Cyclin-dependent kinase 9 | 14 |
| 22037378 | 10.1038/nbt.1990 | Epidermal growth factor receptor | 12 |
| 22037378 | 10.1038/nbt.1990 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 10 |
| 18183025 | 10.1038/nbt1358 | Epidermal growth factor receptor | 10 |
| - | 10.6019/CHEMBL5303304 | Fibroblast | 10 |
| - | 10.6019/CHEMBL5303304 | U2OS | 10 |
| 35925880 | 10.1021/acs.jmedchem.2c00257 | CWR22R | 9 |
| 35925880 | 10.1021/acs.jmedchem.2c00257 | Cyclin-dependent kinase 9 | 9 |
| 18842409 | 10.1016/j.bmcl.2008.09.073 | Mus musculus | 9 |
| 26254279 | 10.18632/oncotarget.4214 | Cyclin-dependent kinase 2 | 9 |
| - | 10.6019/CHEMBL5303304 | HEK-293T | 8 |
Data from ChEMBL 36 via Core Engine